• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Rita Medical Systems allies with Aloka

Article

A developer of minimally invasive cancer therapies, Rita Medical Systems, has signed a copromotion agreement with Aloka, a Japanese maker of diagnostic ultrasound equipment. Under

A developer of minimally invasive cancer therapies, Rita Medical Systems, has signed a copromotion agreement with Aloka, a Japanese maker of diagnostic ultrasound equipment. Under terms of the agreement, each company's U.S. sales force will be trained in the others' products to help identify potential common customers. The two companies will also cooperate on formal physician training programs, cosponsor trade show receptions, and display products and promotional materials at each other's booths at industry shows and conferences. Each company will retain direct control of the sales process for its respective products. Ultrasound is often used to visualize and guide the placement of Rita's radio-frequency ablation devices.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.